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A functional MexAB-OprM efflux system is not necessary to 
Pseudomonas aeruginosa to resist ~-Iactam treatments in cysSc 
fibrosis paSents 
L. Vettoretti, F. El Garch, C. Llanes, P. Pl~siat 
Bacteriology department, EA 3186, Faculty of medecine, Besancm~ France 
According to recent data, Pseudomonas aeruginosa would be much more resistant 
to antibiotics in the CF lung than as determined by conventional in vitro methods. 
Analysis of 28 CF strains isolated ha our laboratory showed that 13 (46%) were both 
hypersusceptible to ticarcil l in and resistant o aminoglycosides (AGs). Eleven 
genotypically different strains exhibit ing this phenotype were investigated further 
by Real Time reverse transcription PCR (RT PCR), DNA sequencing, mad western 
blotting. Al l  these isolates appeared to ovetprodruce the active effiux system 
MexXY which exports AGs, as a result of mutations in the regulatory gene mexZ. 
Since the eff lux system MexAB OprM strongly contributes to the wi ld type 
susceptibility of /~ aeruginosa to [~ lactams including ticarcill in, we  inactivated 
mexB by gene replacement to explore the functionality of this pump. In contrast o 
wi ld  type reference strain PAO1, none of the 11 strains displayed higher 
susceptibility o ticarcil l in mad aztreonam after gene disruption, indicating that their 
MexAB OprM systems were not functional. In addition, gene mexB and its product 
(transporter MexB) were not or poorly expressed in 6/11 strains. Surprisingly, gene 
oprM which is cotr anscribed with mexB ha the me~AB-oprM oper on, and its product 
(outer membrane protein OprM) were found to be expressed at levels similar or 
higher to that of PAO1. As OprM is necessary to form a functional tripartite 
MexXY OprM pump, this study shows that/~ aeruginosa dapts itself to the high 
selective press~are of AGs in vivo by overproducing the corresponding proteins but 
does not require a functional MexAB OprM system to resist 1~ lactams probably 
because of its lifestyle ha the CF sputum. 
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Methicillin Resistant Staphylococcus Aureus(MRSA)infection in 
Cystic Fibrosis(CF) 
C. Ricachinevsky, L. Machado, M. Santos, M. Vieir a, F. Abreu e Si lva 
Department of Paediatrics-CF Unit, Hospital de Clinicas de Porto Alegre, Brazil 
INTRODUCTION: The prevalence of MRSA infection is increasing in patients 
with CF. The aim of this study is to study the effects of MRSA on the clinical status 
of chi ldren with CE 
METHODS:  Al l  CF patients (pts) with positive cultures for MRSA and able to 
perform PFTs were selected and matched for sex and age with controls. Respiratory 
function (FEV1 and FVC) nutritional status, number of hospital admissions/year 
and number of days/year in hospital were compared between the groups. 
RESULTS: The medical records of 26 CF pts were analyzed. Thirteen pts had a 
positive sputum culture for MRSA and 13 pts had MSSA (Methici l l in Sensitive 
St aphylcececus Aureus). 34,65% of the pts were female and 65,4% were male. The 
mean age of MRSA was 140,9 months and 146,6 in MSSA (p 0,66). The FEV 1 for 
the MRSA group was 62,25%, and for controls was 73,78 of predicted (p 0,117). 
The analysis of FVC for the MRSA group was 74,03%; whi le  in pts with MSSA was 
81,88% (p 0,376). The nutritional status was similar in MRSA and non MRSA 
pts.ICM 13,83 vs 10,91for controls(p 0,37). Statistical significance was only found 
on the number of hospital admissions (mean of 2,9/year in MRSA pts and 1,3/year 
in MSSA patients(p0,01), mad in the duration of hospitalization (mean of 79,46 
days/year in MRSA, and 21,69 days/year in MSSA (p 0,~)1 ). 
CONCLUSION: The analysis of our data showed so far that MRSA positive 
patients have an increase of hospital admissions per year as wel l  ha the length of 
hospitalization. The isolation of CF pts for long periods in hospital worsens their 
quality of l ife and the prolonged use of antibiotics is related to high costs, increasing 
side effects and to increasing levels of antibiotic resistance. Therefore we 
emphasize the need of isolation of these pts to curtail pts topts or statt'to pts 
transmission of MRSA. 
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Detection of an integron associated aadb-resistance gene in 
Pseudomonas aeruginosa isolates fTom patients with CF 
M. Syrmis 1"~, M. O'CaTroll l, J. Iredell 4, C.E. Wainwright 5, C. Coulter", T. Sloots 1"~, 
S.C. BelP, M. Nissen 1"~ 
ICVMMR Unit, RCH; 2paediatrics mul Child Health, UQ; 3Adult CF Unit, TPCH; 
4Microbiolog3~ University of Sydne3~ Westmead Hospital, Sydney; ~Respiratmy 
Medicine, RCH, 6Microbiology, QHPS, TPCH, Brisbane 
Previously, we  identified a dominant/~ aeruginosa clone, Pulsotype 2 (P2), ha adult 
and paediatric CF patients. Importantly, this P2 clone was found to have increased 
resistance to the aminoglycosides, compared to unique isolates, hltegrons are an 
acquired resistance mechanism, capable of capturing resistance genes by site 
specific recombination. In this study, PCR was used to investigate he incidence of 
class 1, 2 and 3 integrons and integron located resistance genes in 1CO patients with 
CF. Methods:  163/~ aeruginosa isolates, including 63 P2 isolates and 70 unique 
isolates, obtained from patients with CF. Al l  positive results confirmed by PCR 
targeting different gene sequences and sequencing. Results:  Overall, class 1 
integr ons were detected in 84% (134/163) of isolates. Class 1 integrons were found 
to be more prevalent ha the dominant P2 isolates (97%) than in the tmique isolates 
(74%). In addition, an aminoglycoside r sistance gene, aadB, was detected in the 
variable region of 71% of class 1 integron positive isolates. The aadB has been 
previously shown to confer resistance to amonglycosides. P2 strains were found to 
be significantly more l ikely to carry the aadB gene than the tmique strains (p<0.01). 
A class 2 integr on was only detected in one isolate (tmique strain) whereas no class 
3 integr ons were found. Conclusion: A class 1 integr on associated aminoglycoside 
resistance gene may play a significant role ha the increased resistance of P2 isolates 
to aminoglycosides. 
Supported by A ustralian Cystic Fibrosis Research Trust. 
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Rapid desensitization of intravenous antibioScs in cysSc fibrosis 
paSents with antibiotic allergy 
D. Shoseyov, T. Volt zinger, E. Kerem 
CF Center Hadassah University Hospital, Mount Scopus, Jerusalem, Israel 
Antibiotic desensitization is an option for patients with suspected IgE mediated 
antibiotic allergy when no other alternative exists for treating bacterial infections. 
The prevalence of allergic reactions to beta lactam antibiotics is reported to be 
between 1mad 10% ha the commtmity, and up to 33% in patients with cystic fibrosis. 
There are several IV desensitization protceols in the literature that last 2 4 days 
each. In our center we  use a rapid IV desensitization protocol that starts with a very 
low intravenous dose ( lx l ( t  8 of the ful l  dose) given over 30 minutes, fol lowed by 
an serial incremental 10 fold increase in the dose administered over 30 minutes until 
the desired dosage is achieved. Usually, we administer 8 10 diluted doses over a 
period of 4 to 5 hours prior to each treatment cycle. I f  a reaction appears during 
incremental dosage increases, we  return to the previous dose. 
We present 3 patients with allergic reactions to antibiotics (Cet~azidime mad 
Pipracil l in) who were treated with the rapid IV desensitization protc¢ol (5 
treatments). Four attempts were successful and one attempt failed when urticaria 
developed 6 hours after the end of the desensitization protocol. No severe reactions 
were repotted. We conclude that CF patients with allergic reactions to intravenous 
antibiotics can be safely and in most cases successfully treated by rapid intravenous 
desensitization. It is important o remember that allergic patients should be 
desensitized on each subsequent admission of intravenous therapy. 
